Atlas Trials

Study of Tecovirimat for Human Mpox Virus

Clinical trial NCT05534984 · TERMINATED

Trial details

NCT number
NCT05534984
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
MPOX
Start date
2022-09-08
Primary completion
2024-10-23
Enrollment
719

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.